{
    "clinical_study": {
        "@rank": "156300", 
        "brief_summary": {
            "textblock": "This study will investigate the usefulness of an optical probe in the differentiation of\n      thyroid cancer from normal thyroid tissue in a thyroidectomy specimen."
        }, 
        "brief_title": "The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Thyroid Nodule", 
            "Thyroid Neoplasms", 
            "Thyroid Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Thyroid Neoplasms", 
                "Thyroid Diseases", 
                "Thyroid Nodule"
            ]
        }, 
        "detailed_description": {
            "textblock": "The optical real-time readings will be compared to the histological analysis from the same\n      area. Subjects undergoing thyroid surgery for thyroid disease including thyroid nodules,\n      thyroid cancer and thyroid goiter with nodules will be eligible to participate. After the\n      removal of the thyroid gland, optical readings will be taken from the ex vivo thyroid gland\n      and these same areas will then be analyzed in the usual standard fashion. The reading will\n      then be correlated with the histological results. In addition, if lymph nodes are removed as\n      part of the surgery they will also be tested prior to histological standard processing. All\n      specimens and data will be de-identified."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects undergoing thyroid surgery for thyroid nodules, thyroid cancer, and thyroid\n             goiter with nodules.\n\n        Exclusion Criteria:\n\n          -  Subjects whose thyroid specimens have been put in formalin"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Tertiary hospital setting Urban hospital"
            }
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 8, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01792492", 
            "org_study_id": "H28135"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Thyroid Neoplasms", 
            "Optical Devices", 
            "Spectrum Analysis", 
            "Thyroid diseases"
        ], 
        "lastchanged_date": "February 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02118"
                }, 
                "name": "Boston Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "The Role of an Optical Probe in the Detection of Thyroid Cancer and Normal Thyroid Tissue in a Thyroidectomy Specimen: A Pilot Study", 
        "overall_official": {
            "affiliation": "Boston Medical Center", 
            "last_name": "Jennifer E Rosen, M.D. FACS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The objective is to assess a device called an optical probe for the differentiation of thyroid cancer from normal thyroid tissue, benign thyroid nodules or parathyroid glands, and the detection of thyroid cancer within lymph nodes using a hand-held spectroscope, compare the spectra from benign and malignant thyroid nodules and use this to discriminate benign from malignant nodules based on final histopathology or cytology as the gold standard.", 
            "measure": "Assess optical probe for the differentiation of thyroid cancer from normal thyroid tissue and benign thyroid nodules", 
            "safety_issue": "No", 
            "time_frame": "two years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01792492"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Boston Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boston Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2009", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}